DocSym
β
Searchsearch
Search
(Y51.2) Ganglionic blocking drugs, not elsewhere classified
More details coming soon
17 073 in individuals diagnosis ganglionic blocking drugs, not elsewhere classified confirmed
507 deaths with diagnosis ganglionic blocking drugs, not elsewhere classified
3% mortality rate associated with the disease ganglionic blocking drugs, not elsewhere classified
Diagnosis ganglionic blocking drugs, not elsewhere classified is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis ganglionic blocking drugs, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis ganglionic blocking drugs, not elsewhere classified
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease ganglionic blocking drugs, not elsewhere classified - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features ganglionic blocking drugs, not elsewhere classified
Absence or low individual and public risk
Ganglionic blocking drugs, not elsewhere classified - what does this mean
Ganglionic blocking drugs, not elsewhere classified, are a type of drug that work by blocking the nerve signals that pass through certain nerve cells, known as ganglia, in the body. this can lead to a decrease in the activity of the sympathetic nervous system, which is responsible for regulating certain bodily functions such as heart rate, blood pressure, and respiration.
What happens during the disease - ganglionic blocking drugs, not elsewhere classified
Ganglionic blocking drugs work by blocking the transmission of nerve impulses between the pre- and post-ganglionic neurons in the autonomic nervous system, thereby inhibiting the release of acetylcholine from the pre-ganglionic neurons. this leads to a decrease in sympathetic activity, resulting in a decrease in heart rate, blood pressure, and other autonomic functions.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Ganglionic blocking drugs, not elsewhere classified - Prevention
Ganglionic blocking drugs, not elsewhere classified, can be prevented through lifestyle modifications such as healthy eating, regular exercise, and avoiding smoking and alcohol. additionally, it is important to be aware of any potential side effects of any medications that are being taken, and to seek medical attention if any concerning symptoms arise.